These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8774330)

  • 21. Cine MR imaging of myocardial contractile impairment in patients with hypertrophic cardiomyopathy attributable to Asp175Asn mutation in the alpha-tropomyosin gene.
    Sipola P; Lauerma K; Jääskeläinen P; Laakso M; Peuhkurinen K; Manninen H; Aronen HJ; Kuusisto J
    Radiology; 2005 Sep; 236(3):815-24. PubMed ID: 16014439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy.
    Van Driest SL; Ellsworth EG; Ommen SR; Tajik AJ; Gersh BJ; Ackerman MJ
    Circulation; 2003 Jul; 108(4):445-51. PubMed ID: 12860912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coexistence of mitochondrial DNA and beta myosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failure.
    Arbustini E; Fasani R; Morbini P; Diegoli M; Grasso M; Dal Bello B; Marangoni E; Banfi P; Banchieri N; Bellini O; Comi G; Narula J; Campana C; Gavazzi A; Danesino C; Viganò M
    Heart; 1998 Dec; 80(6):548-58. PubMed ID: 10065021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of mutations in symptomatic patients with hypertrophic cardiomyopathy in Taiwan.
    Chiou KR; Chu CT; Charng MJ
    J Cardiol; 2015 Mar; 65(3):250-6. PubMed ID: 25086479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variable clinical manifestation of a novel missense mutation in the alpha-tropomyosin (TPM1) gene in familial hypertrophic cardiomyopathy.
    Jongbloed RJ; Marcelis CL; Doevendans PA; Schmeitz-Mulkens JM; Van Dockum WG; Geraedts JP; Smeets HJ
    J Am Coll Cardiol; 2003 Mar; 41(6):981-6. PubMed ID: 12651045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coexistence of Digenic Mutations in Both Thin (TPM1) and Thick (MYH7) Filaments of Sarcomeric Genes Leads to Severe Hypertrophic Cardiomyopathy in a South Indian FHCM.
    Selvi Rani D; Nallari P; Dhandapany PS; Rani J; Meraj K; Ganesan M; Narasimhan C; Thangaraj K
    DNA Cell Biol; 2015 May; 34(5):350-9. PubMed ID: 25607779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy.
    Chida A; Inai K; Sato H; Shimada E; Nishizawa T; Shimada M; Furutani M; Furutani Y; Kawamura Y; Sugimoto M; Ishihara J; Fujiwara M; Soga T; Kawana M; Fuji S; Tateno S; Kuraishi K; Kogaki S; Nishimura M; Ayusawa M; Ichida F; Yamazawa H; Matsuoka R; Nonoyama S; Nakanishi T
    Heart Vessels; 2017 Jun; 32(6):700-707. PubMed ID: 27885498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of the genotypes causing hypertrophic cardiomyopathy in northern Sweden.
    Mörner S; Richard P; Kazzam E; Hellman U; Hainque B; Schwartz K; Waldenström A
    J Mol Cell Cardiol; 2003 Jul; 35(7):841-9. PubMed ID: 12818575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Familial hypertrophic cardiomyopathy: genes, mutations and animal models. A review].
    Ramírez CD; Padrón R
    Invest Clin; 2004 Mar; 45(1):69-99. PubMed ID: 15058760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A malignant phenotype of hypertrophic cardiomyopathy caused by Arg719Gln cardiac beta-myosin heavy-chain mutation in a Chinese family.
    Huang X; Song L; Ma AQ; Gao J; Zheng W; Zhou X; Zhang Q; Lu H; Li Y; Liu Y; Hui R
    Clin Chim Acta; 2001 Aug; 310(2):131-9. PubMed ID: 11498078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.
    Van Driest SL; Jaeger MA; Ommen SR; Will ML; Gersh BJ; Tajik AJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Aug; 44(3):602-10. PubMed ID: 15358028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of beta-myosin heavy chain mutations is reflective of their hypertrophic expressivity in patients with hypertrophic cardiomyopathy.
    Abchee A; Marian AJ
    J Investig Med; 1997 Apr; 45(4):191-6. PubMed ID: 9154300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diastolic ventricular dysfunction as a marker for hypertrophic cardiomyopathy in a family with a novel alpha-tropomyosin mutation.
    Earing MG; Ackerman MJ; O'Leary PW
    J Am Soc Echocardiogr; 2003 Jun; 16(6):698-702. PubMed ID: 12778034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A de novo mutation in alpha-tropomyosin that causes hypertrophic cardiomyopathy.
    Watkins H; Anan R; Coviello DA; Spirito P; Seidman JG; Seidman CE
    Circulation; 1995 May; 91(9):2302-5. PubMed ID: 7729014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of the risk of sudden death in hypertrophic cardiomyopathy].
    Sadoul N; de Chillou C; Aliot E; McKenna WJ
    Arch Mal Coeur Vaiss; 1999 Apr; 92 Spec No 1():65-73. PubMed ID: 10326160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac troponin T Arg92Trp mutation and progression from hypertrophic to dilated cardiomyopathy.
    Fujino N; Shimizu M; Ino H; Okeie K; Yamaguchi M; Yasuda T; Kokado H; Mabuchi H
    Clin Cardiol; 2001 May; 24(5):397-402. PubMed ID: 11346248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere.
    Thierfelder L; Watkins H; MacRae C; Lamas R; McKenna W; Vosberg HP; Seidman JG; Seidman CE
    Cell; 1994 Jun; 77(5):701-12. PubMed ID: 8205619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence of genetic heterogeneity of hypertrophic cardiomyopathy in eight Chinese patients.
    Hwang DS; Chen YT; Su JS; Hu WH; Wang KY; Ting CT
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 May; 57(5):315-21. PubMed ID: 8768378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.
    Van Driest SL; Vasile VC; Ommen SR; Will ML; Tajik AJ; Gersh BJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Nov; 44(9):1903-10. PubMed ID: 15519027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First-pass MR imaging in the assessment of perfusion impairment in patients with hypertrophic cardiomyopathy and the Asp175Asn mutation of the alpha-tropomyosin gene.
    Sipola P; Lauerma K; Husso-Saastamoinen M; Kuikka JT; Vanninen E; Laitinen T; Manninen H; Niemi P; Peuhkurinen K; Jääskeläinen P; Laakso M; Kuusisto J; Aronen HJ
    Radiology; 2003 Jan; 226(1):129-37. PubMed ID: 12511681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.